Israel’s Teva has received FDA approval for Weltruza, a monthly injection for adults with schizophrenia. The long-acting injectable contains the antipsychotic olanzapine to help patients who have difficulty taking daily medications. (But not in UK pharmacies.)
https://www.calcalistech.com/ctechnews/article/e2s62jq0k
https://thedailybritain.co.uk/royal-college-pharmacy-teva-israel-palestine/